Simpson Adam K.

Chief Executive Officer, DirectorIcosavax, Inc. (ICVX) · full profile →Form 4 · filed Feb 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$229K
Net Open-Market Flow
-$229K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2024Sell(S)15K$15.29$229K359K
Feb 1, 2024Gift(G)7K$0525K
Feb 1, 2024Option exercise(M)15K$1.04$16K374K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2024Option exercise(M)15K$0191K

Transaction Codes

S
Open-market sale
G
Gift
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-010798) within minutes of acceptance. Every field above traces to the original document. Verify it directly: